Toripalimab (anti-PD-1) is the first domestic anti-tumor PD-1 antibody in China. Toripalimab (anti-PD-1) is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab (anti-PD-1) is able to bind to PD-1 and block the interaction with its ligands. Toripalimab (anti-PD-1) has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma.Purity:>:95% (SDS-PAGE&:SEC):Endotoxin Level:<: 1.0EU/mg Specifications and Purity: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
- UPC:
- 51281504
- Condition:
- New
- Availability:
- 8-12 weeks
- Weight:
- 1.09 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab182801-10mg
- CAS:
- 1924598-82-2
- Product Size:
- 10mg
